Stay updated on Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new history entry on 2025-12-26 adds a Study Status update (version 48). A prior entry from 2025-12-02 was removed.SummaryDifference0.2%

- Check16 days agoChange DetectedFooter changes include a new Revision: v3.3.3 in the page header/footer and removal of the HHS Vulnerability Disclosure link (and related Revision: v3.3.2) on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedResults have been posted for NCT04777331, including the Outcome Measures (Results). The Study Status has been updated, and the page now displays the results section alongside the existing study details.SummaryDifference0.4%

- Check38 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2; no changes to the study history content are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedFooter revision tag updated from v3.2.0 to v3.3.1 on the Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedNotice about government funding and potential updates delay was removed from the page. This may impact users' perception of data timeliness on the record history page.SummaryDifference0.4%

Stay in the know with updates to Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.